The endothelial biology of sickle cell disease

Journal of Laboratory and Clinical Medicine

Volumn 129, Issue 3, 1997, Pages 288-293

  Hebbel, Robert P ^a   Vercellotti, Gregory M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031106184     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90176-1     Document Type: Review

References (59)

1. Pober JS, Cotran RS. The role of endothelial cells in inflammation. Transplantation 1990;50:537-44.
2. Rodgers GM. Hemostatic properties of normal and perturbed vascular cells. FASEB J 1988;2:116-23.
3. Esmon CT. The regulation of natural anticoagulant pathways. Science 1987;235:1348-52.
4. Muller-Berghaus G. Septicemia and the vessel wall. In: Verstraete M, Vermylen J, Lijnen HR, Arnout J, editors. Thrombosis and haemostasis. 1987:619-66.
5. Brenner BM, Troy JL, Ballermann BJ. Endothelium-dependent vascular responses: mediators and mechanisms. J Clin Invest 1989;84:1373-8.
6. Pober JS. Cytokine-mediated activation of vascular endothelium: physiology and pathology. Am J Pathol 1988;133:426-33.
7. Favaloro DJ. Differential expression of surface antigens on activated endothelium. Immunol Cell Biol 1993;71:571-81.
8. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991;67: 1033-6.
9. Brown Z, Gerritsen ME, Carley WW, Strieter RM, Kunkel SL, Westwick J. Chemokine gene expression and secretion by cytokine-activated human microvascular endothelial cells. Differential regulation of monocyte chemoattractant protein-1 and interleukin-8 in response to interferon-gamma. Am J Pathol 1994;145:913-21.
10. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25.
11. Cheresh DA. Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc Natl Acad Sci USA 1987;84:6471-5.
12. Lafrenie RM, Podor TJ, Buchanan MR, Orr FW. Up-regulated biosynthesis and expression of endothelial cell vitronectin receptors enhances cancer cell adhesion. Cancer Res 1982;52:2202-8.
13. 3) in human endothelial cells. J Biol Chem 1991;266:7638-45.
14. Albelda SM, Buck CA. Integrins and other cell adhesion molecules. FASEB J 1990;4:2868-80.
15. Swerlick RA, Garcia-Gonzalez E, Kubota Y, Xu Y, Lawley TJ. Studies of the modulation of MHC antigen and cell adhesion molecule expression on human dermal microvascular endothelial cells. J Invest Dermatol 1991;97:190-6.
16. Lasky LA. Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science 1992;258: 964-9.
17. Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda H, Tandon NN, Jamieson GA. Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood 1992;80:1105-15.
18. Swerlick RA, Lee KH, Wick TM, Lawley TJ. Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. J Immunol 1992;148:78-83.
19. Konkle BA, Shapiro SS, Asch AS, Nachman RL. Cytokineenhanced expression of glycoprotein Iba in human endothelium. J Biol Chem 1990;265:19833-8.
20. Asch AS, Adelman B, Fujimoto M, Nachman RL. Identification and isolation of a platelet GPIb-like protein in human umbilical vein endothelial cells and bovine aortic smooth muscle cells. J Clin Invest 1988;81:1600-7.
21. Dejana E, Corada M, Lampugnani MG. Endothelial cell-to-cell junctions. FASEB J 1995;9:910-8.
22. Speiser W, Anders E, Preissner KT, Wagner O, Müller-Bergbaus G. Differences in coagulant and fibrinolytic activities of cultured human endothelial cells derived from omental tissue microvessels and umbilical veins. Blood 1987;69: 964-7.
23. Dupuy E, Bikfalvi A, Rendu F, Levy Tolendano S, Tobelem G. Thrombin mitogenic responses and protein phosphorylation are different in cultured human endothelial cells derived from large and microvessels. Exp Cell Res 1989;185:363-72.
24. Zwaginga JJ, de Boer HC, IJsseldik MJW, Kerkhof A, Muller-Berghaus G, Gruhlichhenn J, et al. Thrombogenicity of vascular cells. Comparison between endothelial cells isolated from different sources and smooth muscle cells and fibroblasts. Arteriosclerosis 1990;10:437-48.
25. Varani J, Ward PA. Mechanisms of neutrophil-dependent and neutrophil-independent endothelial cell injury. Biological Signals 1994;3:1-14.
26. Platt OS, Thorington BD, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-44.
27. Francis RB Jr, Hebbel RP. Hemostasis. In: Embury S, Hebbel RP, Mohandas N, Steinberg MH, editors. Sickle cell disease: basic principles and clinical practice. New York: Raven Press, 1994:299-310.
28. Kurantsin-Mills J, Ofosu FA, Safa TK, Siegel RS, Lessin LS. Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients. Br J Haematol 1992;81:539-44.
29. Kucuk O, Gilman-Sachs A, Beaman K, Lis LJ, Westerman MP. Antiphospholipid antibodies in sickle cell disease. Am J Hematol 1993;42:380-3.
30. Cariou R, Tobelem G, Bellucci S, Soria J, Soria C, Maclouf J, et al. Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells - inhibition of thrombomodulin-dependent protein C activation. Thromb Haemost 1988; 60:54-8.
31. Schorer AE, Wickham NWR, Watson KV. Lupus anticoagulant induces a selective defect in thrombin-mediated endothelial prostacyclin release and platelet aggregation. Br J Haematol 1993;71:399-407.
32. Faller DV. Vascular modulation. In: Embury S, Hebbel RP, Mohandas N, Steinberg MH, editors. Sickle cell disease: basic principles and clinical practice. New York: Raven Press, 1994:235-46.
33. Longenecker G, Culberson D, Beyers B, Manci E, Mankad V: Plasma endothelin (ET) levels are elevated in sickle cell disease (SCD)[abstract]. Blood 1991;78(suppl):414a.
34. Rybicki AC, Musto S, Swinson GI, Benjamin LJ, Nagel RL, Schwartz RS. Increased levels of endothelin-1 in plasma of sickle cell anemia patients [abstract]. Blood 1991;78(suppl): 202a.
35. Rodgers GP, Schechter AN, Noguchi CT, Klein HG, Nienhuis AW, Bonner RF. Periodic microcirculatory flow in patients with sickle-cell disease. N Engl J Med 1984;311:1534-8.
36. Phelan M, Perrine SP, Brauer M, Faller DV. Sickle: erythrocytes, after sickling, regulate the expression of the endothelia-1 gene and protein in human endothelial cells in culture. J Clin Invest 1995;96:1145-51.
37. Mosseri M, Bartlett-Pandite AN, Wenc K, Isner MH, Weinstein R. Inhibition of endothelium-dependent vasorelaxation by sickle erythrocytes. Am Heart J 1993;126:338-46.
38. Hebbel RP, Mohandas N. Sickle cell adherence. In: Embury S, Hebbel RP, Mohandas N, Steinberg MH, editors. Sickle cell disease: basic principles and clinical practice. New York: Raven Press, 1994:217-30.
39. + sickle reticulocytes to endothelial cells. Blood 1992;80:2634-42.
40. 1-integrin expression on sickle reticulocytes: vascular cell adhesion molecule-1-dependent binding to endothelium. Blood 1993;82:1891-9.
41. Wick TM, Moake JL, Udden MM, Eskin SG, Sears DA, McIntire LV. Unusually large von Willebrand factor multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flow. J Clin Invest 1987;80: 905-10.
42. Hebbel RP, Moldow CF, Steinberg MH. Modulation of erythrocyte-endothelial interactions and the vasocclusive severity of sickling disorders. Blood 1981;58:947-52.
43. Dampler CD, Stuart MJ. Hypoxia enhances red blood cell (RBC)-endothelial cell (EC) adherence. Role of 15-hydroxy-eicosatetraenoic acid (15-HETE) in this interaction. Clin Res 1993;41:163A.
44. Hebbel RP, Visser MR, Goodman JL, Jacob HS, Vercellotti GM. Potentiated adherence of sickle erythrocytes to endothelium infected by virus. J Clin Invest 1987;80:1503-6.
45. Brittain HA, Eckman JR, Wick TM. Sickle erythrocyte adherence to large vessel and microvascular endothelium under physiologic flow is qualitatively different. J Lab Clin Med 1992;120:538-45.
46. Thomson APJ, Dick M. Endotoxinaemia in sickle cell disease. Clin Lab Haematol 1988;10:397-401.
47. Francis RB Jr, Haywood HJ. Elevated plasma immunoreactive tumor necrosis factor-alpha in sickle cell disease. J Natl Med Assoc 1992;84:611-5.
48. Klug PP, Kaye N, Jensen WN. Endothelial and vascular damage in the sickle cell disorders. Blood Cells 1982;8:175-84.
49. Stockman JA, Nigro MA, Mishkin MM, Oski FA. Occlusion of the large cerebral vessels in sickle-cell anemia. N Engl J Med 1972;287:846-8.
50. Russell MO, Goldberg HI, Hodson A. Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood 1984;63:162-7.
51. Rothman SM, Fulling KH, Nelson JS. Sickle cell anemia and central nervous system infarction: a neuropathological study. Ann Neurol 1986;20:684-94.
52. Blei F, Fancher T, Guarini L. Elevated levels of circulating molecules of potential endothelial origin in sickle cell disease. Blood 1994;81(suppl 1):409a.
53. Sowemimo-Coker SO, Haywood LJ, Meiselman HJ, Francis RB Jr. Effects of normal and sickle erythrocytes on prostacyclin release by perfused human umbilical cord veins. Am J Hematol 1992;40:276-82.
54. Wautier J-L, Pintigny D, Maclouf J, Wautier M-P, Corvazier E, Caen J. Release of prostacyclin after erythrocyte adhesion to cultured vascular endothelium. J Lab Clin Med 1986;107: 210-5.
55. Weinstein R, Zhou M, Bartlett-Pandite A, Wenc K. Sickle erythrocytes inhibit human endothelial cell DNA synthesis. Blood 1990;76:2146-52.
56. Sowemimo-Coker SO, Meiselman HJ, Francis RB Jr. Increased circulating endothelial cells in sickle cell crisis. Am J Hematol 1989;31:263-5.
57. George F, Toulon P, Sampol J, Sultan Y. Detection of high levels of circulating endothelial cells in patients with sickle cell crisis [abstract]. Blood 1992;80(suppl):12a.
58. Solovey A, Lin Y, Browne PV, Wayner E, Choong S, Hebbel RP. Phenotypic analysis of circulating endothelial cells reveals an activated endothelium in sickle cell anemia patients. Blood 1996;88(suppl)648a.
59. Lefer DJ, McLeond DS, Merges C, Lutty GA. Immunolocalization of ICAM-1 (CD54) in the posterior eye of sickle cell and diabetic patients [abstract]. Invest Ophthalmol Vis Sci 1993;34:1206.